semaglutide 7.2mg FDA has approved a new, higher-dose 7.2 mg weekly injection of #Wegovy (# semaglutide) for long-term weight management in adults with obesity or overweight. 🔹Indication: It is intended as a “step-up” therapy for Subscription Box National - NEWS: NIH Flavor:Chocolate Chip Pecan

semaglutide 7.2mg FDA has approved a new, higher-dose 7.2 mg weekly injection of #Wegovy (# semaglutide) for long-term weight management in adults with obesity or overweight. 🔹Indication: It is intended as a “step-up” therapy for Subscription Box National - NEWS: NIH Flavor:Chocolate Chip Pecan

National - NEWS: NIH scientists have unveiled new details about the events GLP-1 receptor agonists trigger within neurons, which have been largely unexplored until now. The team identified key intracellular signaling processes

To put those numbers in context that matters for Canadian researchers: a person starting at 160 lbs loses approximately 39 lbs at the 12mg dose

Subscription Box

Flavor:Chocolate Chip Pecan

Sudha Seshadri, founding director of the Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio